ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2026
[Influencing Factors for Secondary Fungal Infections in Systemic Lupus Erythematosus].
Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the influencing factors for secondary fungal infections in patients with systemic lupus erythematosus (SLE). Methods: A total of 310 SLE patients admitted to our hospital between June 2021 and January 2025 were retrospectively enrolled. They were divided into an infection group and a non-infection group based on the presence or absence of secondary fungal infections. After 5:1 matching using propensity score matching (PSM), 230 patients in the non-infection group and 46 patients in the infection group were included in the final analysis. The characteristics of secondary fungal infections in patients with SLE were analyzed. Logistic regression analysis was performed to identify factors associated with secondary fungal infections, and receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive performance of the model. A nomogram model for predicting secondary fungal infections in SLE patients was subsequently established. Results: Among the 310 SLE patients enrolled, fungal infection occurred in 46 cases (14.84%), predominantly involving the lung (50.0%) and the gastrointestinal tract (23.9%). After PSM, binary logistic regression analysis revealed that lupus disease activity (odds ratio [OR] = 10.734, 95% CI: 2.015-57.184), duration of antibiotic use (OR = 13.826, 95% CI: 2.995-63.822), C-reactive protein (CRP) (OR = 9.927, 95% CI: 1.024-96.188), white blood cell (WBC) count (OR = 11.784, 95% CI: 1.568-88.553), complement C4 (OR = 16.392, 95% CI: 3.899-68.909), and 24-hour urine protein (24 h Pro) (OR = 9.391, 95% CI: 1.195-73.813) were independent risk factors for secondary fungal infections in SLE patients (all Conclusion: Lupus activity, duration of antibiotic use, CRP, WBC, complement C4, and 24 h Pro are the influencing factors of secondary fungal infection in SLE patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.